Oxydifficidin’s anti-N. gonorrhoeae activity arises from a combination of DedA flippase assisted uptake and ribosomal protein L7/L12 (RplL) sensitivity.
a. Structure of oxydifficidin compared to that of the known substrates for DedA homologs. b. Comparison of antibiotic accumulation in WT and dedA knockout cells. Blue and yellow highlighted sections represent independent experiments. (Oxydifficidin and Tetracycline: n = 2; Oxydifficidin and chloramphenicol: n = 3) c. In vitro coupled transcription/translation assay. The effect of oxydifficidin and other antibiotics on in vitro protein production using a coupled transcription/translation system was monitored by SDS-PAGE. Red dots indicate in vitro production of dihydrofolate reductase (18 kDa) from the DHFR gene. MW std: kDa molecular weight standard. d. In vitro transcription assay. Red dots indicate in vitro production of a 1704 bp RNA from the FLuc gene. A reaction containing 20 mM of EDTA was used as an inhibition control. MW std: bp molecular weight standard. e. Model explaining oxydifficidin’s potent activity in N. gonorrhoeae. In this model DedA flips oxydifficidin across the inner membrane to assist its uptake and oxydifficidin then inhibits protein synthesis through either a direct or indirect interaction with L7/L12 (RplL). Two spontaneous mutations (K84E and R76C) in the RplL (L7/L12) protein were found to confer resistance to oxydifficidin. Image was generated by BioRender.
© 2024, BioRender Inc. Any parts of this image created with BioRender are not made available under the same license as the Reviewed Preprint, and are © 2024, BioRender Inc.